Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 10, 2023
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
Richard Newitter Maintained (TMCI) at Strong Buy with Decreased Target to $12 on, Nov 10th, 2023
Richard Newitter of Truist Securities, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $17 to $12 on, Nov 10th, 2023.
Richard has made no other calls on TMCI in the last 4 months.
There are 3 other peers that have a rating on TMCI. Out of the 3 peers that are also analyzing TMCI, 1 agrees with Richard's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- George Sellers of "Stephens & Co." Reiterated at Hold and Held Target at $25 on, Tuesday, September 12th, 2023
These are the ratings of the 2 analyists that currently disagree with Richard
- Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $24 on, Friday, September 29th, 2023
- Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, August 28th, 2023
